Immunovant Inc Earnings

The next earnings date for Immunovant Inc is October 31, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Immunovant Inc Earnings

Report Date	Estimated Earnings Per Share
10/31/2025	$-0.73

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Immunovant Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$0	100.00%
02/10/2025	Before Market	$-0.76	-1.02%
11/07/2024	Before Market	$-0.74	-23.33%
08/06/2024	After Market	$-0.60	-13.21%
05/29/2024	After Market	$-0.52	-20.93%
02/12/2024	Before Market	$-0.36	16.28%
11/09/2023	Before Market	$-0.45	4.26%
08/10/2023	Before Market	$-0.57	-26.67%
05/22/2023	Before Market	$-0.46	-6.98%
02/03/2023	Before Market	$-0.49	-25.64%
11/04/2022	Before Market	$-0.41	-5.13%
08/05/2022	Before Market	$-0.35	12.50%
06/08/2022	Before Market	$-0.41	-7.89%
02/04/2022	Before Market	$-0.36	-9.09%
11/05/2021	Before Market	$-0.35	-25.00%
08/09/2021	Before Market	$-0.31	0.00%
06/01/2021	Before Market	$-0.29	12.12%
02/16/2021	Before Market	$-0.32	-23.08%
11/12/2020	Before Market	$-0.25	26.47%
08/12/2020	After Market	$-0.38	-15.15%
06/29/2020	Before Market	$-0.38	7.32%
02/14/2020	Before Market	$-0.28	-12.00%
11/06/2019	After Market	$-0.25	---
08/12/2019	---	$0.01	---
06/12/2019	---	$0	---

More About Immunovant Inc

Website

https://immunovant.com

Country

USA

Full Time Employees

362

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

“Immunovant Inc Earnings” Can Refer to the Immunovant Inc Earnings Date

Some people say “Immunovant Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Immunovant Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Immunovant Inc Stock on the Earnings Date

If you own Immunovant Inc stock (IMVT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Immunovant Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Immunovant Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Immunovant Inc Earnings

You can contact us any time if you would like to ask questions about Immunovant Inc earnings or anything else related to the stock market.